| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.7M | -57.7% | — |
| Cost of Revenue | $329K | -58.3% | — |
| Gross Profit | $1.3M | -57.6% | — |
| R&D Expense | $1.1M | +6.0% | -65.6% |
| SG&A Expense | $23.6M | +726.3% | +953.2% |
| Operating Income | -$28.6M | -444.8% | -283.0% |
| Pre-tax Income | -$26.8M | -409.3% | -259.3% |
| Income Tax | -$231K | -187.5% | -187.5% |
| Net Income | -$26.6M | -380.8% | -244.0% |
| EPS (Basic) | -$0.27 | -350.0% | -145.5% |
| EPS (Diluted) | -$0.27 | -350.0% | -145.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.6M | -63.9% | — |
| Accounts Receivable | $1.1M | -73.4% | — |
| Inventory | $22.7M | +0.1% | +47.7% |
| Current Assets | $29.4M | -20.8% | +63.1% |
| Total Assets | $100.7M | -8.4% | +10.1% |
| Current Liabilities | $58.8M | +31.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.2M | -52.1% | — |
| Investing Cash Flow | -$5.0M | -13.6% | — |
| Financing Cash Flow | $14.9M | -1.5% | — |
| +18.2% |
| Total Liabilities | $65.4M | +26.9% | +17.3% |
| Stockholders' Equity | $35.3M | -39.6% | -1.0% |